换一批Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
作者：
Jung, Kyung Hae [1]
;
LoRusso, Patricia [2]
;
Burris, Howard [3]
;
Gordon, Michael [4]
;
Bang, Yung-Jue [5]
;
Hellmann, Matthew D. [6]
;
Cervantes, Andres [7]
;
Ochoa de Olza, Maria [8]
;
Marabelle, Aurelien [9]
;
Hodi, Stephen [10]
;
Ahn, Myung-Ju [11]
;
Emens, Leisha A. [12]
;
Barlesi, Fabrice [13]
;
Hamid, Omid [14]
;
Calvo, Emiliano [15]
;
McDermott, David [16]
;
Soliman, Hatem [17]
;
Rhee, Ina [18]
;
Lin, Ray [19]
;
Pourmohamad, Tony ;
Suchomel, Julia ;
Tsuhako, Amy ;
Morrissey, Kari ;
Mahrus, Sami ;
Morley, Roland ;
Pirzkall, Andrea ;
Davis, S. Lindsey
作者单位：
Univ Paris Saclay, Dept Innovat Therapeut & Essais Precoces, Gustave Roussy, INSERM U1015
[1]
HonorHlth Res Inst, Scottsdale, AZ USA
[2]
Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3]
Angeles Clin & Res Inst, Los Angeles, CA USA
[4]
Genentech Inc, San Francisco, CA 94080 USA
[5]
Hosp HM Sanchinarro, CIOCC, START Madrid, Madrid, Spain
[6]
Sarah Cannon Res Inst, Nashville, TN USA
[7]
Moffit Canc Ctr & Res Inst, Tampa, FL USA
[8]
Yale Canc Ctr, New Haven, CT USA
[9]
Johns Hopkins Bloomberg Kimmel Inst Canc Immunoth, Baltimore, MD USA
[10]
Seoul Natl Univ, Coll Med, Seoul, South Korea
[11]
Dana Farber Canc Ctr, Boston, MA USA
[12]
Univ Colorado, Canc Ctr, Aurora, CO USA
[13]
Univ Ulsan, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[14]
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[15]
Hosp Univ Vall dHebron, Barcelona, Spain
[16]
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17]
Univ Valencia, Biomed Res Inst INCLIVA, CIBERONC, Dept Med Oncol,Biomed Res Inst, Valencia, Spain
[18]
Aix Marseille Univ, Marseille, France
[19]
发布时间
2019-10-16
- 浏览2
Clinical cancer research
Clinical cancer research
3220-3228页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
